# CellMEAT

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellmeat

- Industry: Consumer Products
- Headquarters: Gwangju, South Korea
- Website: http://www.thecellmeat.com
- Total disclosed funding: $8.1M
- Latest round: Series A (Jun 6, 2023)
- Investors on record: 8

## About

Founded in 2019 and based in Gwangju, South Korea, cellmeat CO., LTD. operates as a provider of cultured meat enable to produce meat without killing animals. The company was founded by Giljun Park. In February 2021, the company received KRW 5 billion in Pre-Series A funding from NAU IB Capital, BNK Venture Capital, DT & Investment, Ryu Kyung PSG Asset Management, JNU Holdings, Yonsei Technology Holdings, and Baltimore.

The company offers cultured meat also known as "GogiMEAT" a non-slaughter-free fetal bovine serum (FBS) and cell-based culture of animal cells. The company's aim to improve the economic production and market issues by producing cultured meat enable to avoid animal slaughter.

As of February 2021, the company plans to lower the cost of production to compete with conventional meat, as well as further refining its technology to ensure that cell-based proteins can rival the taste and texture of their animal-based counterparts.

## Funding rounds

- Series A, Jun 6, 2023, $0M — Strong Ventures, BNK Venture Capital, Ryukyung PSG Asset Management, NH Venture Investment, Genting Ventures, Daewoodang Healthcare Co., Ltd.
- Series A, Apr 22, 2022, $8.1M — Strong Ventures, BNK Venture Capital, Ryukyung PSG Asset Management
- Seed, Dec 1, 2019 — Primer, Korea Tech Incubator for Startup

## Investors

- Primer (https://capitalatlas.ai/funds/primer) — Seed
- Korea Tech Incubator for Startup — Seed
- Strong Ventures (https://capitalatlas.ai/funds/strong-ventures) — Series A
- BNK Venture Capital (https://capitalatlas.ai/funds/bnk-venture-capital) — Series A
- Ryukyung PSG Asset Management — Series A
- NH Venture Investment (https://capitalatlas.ai/funds/nh-venture-investment) — Series A
- Genting Ventures (https://capitalatlas.ai/funds/genting-ventures) — Series A
- Daewoodang Healthcare Co., Ltd. — Series A